Clinical trials of a new treatment for asthma that uses an innovative inhaler system developed by Chippenham-based specialist pharma group Vectura have started. The move follows successful pre-clinical tests for the product, known at this stage as VR942, which has been developed with Belgian biopharma giant UCB. The two firms have been collaborating on...